Nancy Dezutter, PhD, PharmD

Lead Vaccine Development Leader Older Adult Immunization
GSK, Wavre, Belgium
Wavre, Brabant Wallon, Belgium

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 1936 - Efficacy of One Dose of the Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Adults ≥ 60 Years of Age Persists for 2 RSV Seasons

  Friday, October 13, 2023
  2:09 PM – 2:21 PM US ET